<DOC>
	<DOCNO>NCT00421005</DOCNO>
	<brief_summary>Statin therapy treatment proven positive impact survival heart transplantation . However , unclear whether beneficial effect class drug depend solely LDL-lowering property anti-inflammatory immuno-modulatory property . Thus , study design compare safety efficacy two different strategy : 1. high fix statin dose vs. 2. low start dose LDL-driven dos adjustment .</brief_summary>
	<brief_title>Fluvastatin After Heart Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>De novo heart transplantation Known allergy/intolerance fluvastatin ; Preexisting neuromuscular disorder ; Significant liver disease and/or elevation transaminase exceed 3 time ULN Severe renal impairment : creatinine &gt; 3 mg/dL Intellectual/cognitive impairment likely compromise inform consent adherence protocol age &lt; 18 year . Patients refusal Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>